skip to primary navigationskip to content

Maximilian Stammnitz

Maximilian Stammnitz

PhD student


Max is working on Tasmanian Devil Transmissible Cancer genetics, covering mainly computational analyses of next-generation DNA and RNA sequencing. He is a Gates Cambridge scholar and has joined the Transmissible Cancer Group in 2015.


Key Publications

Kwon, Y.M., Stammnitz, M.R., Wang, J., Swift, K., et al. (2018). Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases. Royal Society Open Science 5:180870. doi:10.1098/rsos.180870

Caldwell, A., Coleby, R., Tovar, C., Stammnitz, M.R., et al. (2018). The newly-arisen Devil Facial Tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer. eLife 7:e35314. doi:10.7554/eLife.35314

Stammnitz, M.R., *Coorens, T.H.H., *Gori, K.C., Hayes, D., et al. (2018). The origins and vulnerabilities of two transmissible cancers in Tasmanian devils. Cancer Cell 33(4), 607-619. doi:10.1016/j.ccell.2018.03.013

Giordano, F., Stammnitz, M.R., Murchison, E.P., Ning, Z. (2018). scanPAV: a pipeline for extracting presence-absence variations in genome pairs. Bioinformatics 34(17), 3022–3024. doi:10.1093/bioinformatics/bty189

*Agne, M., *Blank, I., *Emhardt, A.J., *Gäbelein, C.G., ..., *Stammnitz, M.R., et al. (2014). Modularized CRISPR/dCas9 Effector Toolkit for Target-Specific Gene Regulation. ACS Synthetic Biology 3(12). doi:10.1021/sb500035y

Human anti-cancer drugs could help treat transmissible cancers in Tasmanian devils

« April 2019 »